TELESIS BIO (TBIO)
(Delayed Data from OTC)
$2.85 USD
+0.10 (3.64%)
Updated Oct 11, 2024 03:59 PM ET
NA Value
NA Growth NA Momentum NA VGMEarnings News For TBIO
-
Telesis Bio: Q2 Earnings Snapshot
-
Telesis Bio Reports Second Quarter and First Half 2024 Financial Results
-
Telesis Bio: Q1 Earnings Snapshot
-
Telesis Bio Reports First Quarter 2024 Financial Results
-
Telesis Bio: Q4 Earnings Snapshot
-
Telesis Bio: Q4 Earnings Snapshot
-
Telesis Bio Reports Fourth Quarter and Full Year 2023 Financial Results
-
Telesis Bio Reports Third Quarter 2023 Financial Results
-
Telesis Bio Reports Second Quarter 2023 Financial Results
-
Telesis Bio (TBIO) Reports Q1 Loss, Misses Revenue Estimates
-
Telesis Bio Reports First Quarter 2023 Financial Results
-
Telesis Bio (TBIO) Reports Q4 Loss, Tops Revenue Estimates
-
Telesis Bio Reports Fourth Quarter and Full Year 2022 Financial Results and Provides 2023 Guidance
-
Will Translate Bio, Inc. (TBIO) Report Negative Q2 Earnings? What You Should Know
-
Translate Bio, Inc. (TBIO) Reports Q1 Loss, Misses Revenue Estimates
-
Will Translate Bio, Inc. (TBIO) Report Negative Q1 Earnings? What You Should Know
-
Translate Bio, Inc. (TBIO) May Report Negative Earnings: Know the Trend Ahead of Q4 Release
-
Is a Beat in Store for Translate Bio (TBIO) in Q2 Earnings?
-
Translate Bio, Inc. (TBIO) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
-
Translate Bio Inc (TBIO) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
-
Translate Bio, Inc. (TBIO) Reports Q4 Loss, Tops Revenue Estimates
-
Earnings Preview: Translate Bio, Inc. (TBIO) Q4 Earnings Expected to Decline
-
Translate Bio, Inc. (TBIO) Reports Q3 Loss, Lags Revenue Estimates
-
Translate Bio, Inc. (TBIO) Reports Q2 Loss, Lags Revenue Estimates